Stock & Company Details
Ionis Pharmaceuticals Inc $IONS
Price:
N/A
N/A
167M
$4.5B
52 Week High:
N/A
10 Day Average Volume:
N/A
-7.84
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IONS technical indicators
Latest Ionis Pharmaceuticals Inc (IONS) indicator readings as of 2026-11-19.
IONS's 14-day RSI is 23.3, in oversold territory. ADX reads 48.4, indicating a trending market. MACD (12, 26, 9) is -4.81, below the zero line.
Overview
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Finance Bot
Ask your questions
Start by typing a question below.